Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This target is a **pseudogene** associated with the eukaryotic translation initiation factor 3 (eIF3) complex, specifically a subunit I/alpha. The eIF3 complex is a large, multi-subunit factor essential for the initiation of translation in eukaryotes and is involved in recruiting the 40S ribosomal subunit, mRNA, and initiator tRNA for protein synthesis[3]. However, this entry corresponds to a pseudogene, meaning it does **not encode a functional protein** and does not have a canonical biological role. Pseudogenes can occasionally be transcribed or have regulatory functions, but there is **no evidence that this particular pseudogene serves as a therapeutic target, biomarker, or that it is implicated directly in disease or drug response**. The core eIF3 complex and its functional subunits (such as eIF3J, eIF3I, etc.) are crucial in translation and sometimes in cancer biology, but **pseudogenes are generally excluded from such roles**[1][3][7]. ### Additional interpretive notes: - The **Ensembl ID ENSG00000225122** designates this gene as a *pseudogene*, not a protein-coding gene. - It is not considered a canonical or therapeutic target in human disease or drug development. - If you intended to retrieve data on a functional protein (such as eIF3I or eIF3J), consider using the specific protein-coding gene, not the pseudogene. - There is **nothing erroneous in the name itself** if referring to the pseudogene, but if the intent was to identify a functional, druggable target, **this entry is not correct**.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation initiation factor 3 subunit I pseudogene (EIF3IP1).